The U.S. could authorize the firing of Pfizer COVID-19 for children ages 5 to 11 in October, according to sources
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BGA77H52OVP6RPKR57A6ZVWABA.jpg "The Australian state of NSW says the rate of coronavirus vaccination is slowing")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3M6EZH7B3FKAZFLYT5GKEEHHZI.jpg "Britain is launching the world’s largest blood test for 50 cancers")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5W5SVMQUMFMDVNYOKU6PM55YLY.jpg "Australia buys additional doses of 1 million COVID-19 vaccines from Moderna")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GGF544HPPRK2VLHWSNEWYFYVKQ.jpg "The U.S. could authorize the firing of Pfizer COVID-19 for children ages 5 to 11 in October, according to sources")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LGDRTWA5SBP2VGI7T7DSJDCVD4.jpg "Novavax expects to make at least 2 trillion doses of COVID-19 vaccine available in 2022")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ASAZC3JCXRPIFPVR2YH36VZQQI.jpg "COVID-19 vaccines remain strong against Delta, decreasing protection in older adults")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/XA3ISOF3EROIZE3YJWGU3K4IF4.jpg "BioNTech will soon apply for the vaccine for children ages 5-11-Spiegel")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/LQFWGPLJJBMOJINEG2ZQBL52BE.jpg "Novavax is initiating an initial phase trial for the combined influenza / COVID-19 vaccine")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/67LSBJKEKVMGXE2ACG52UAV67Y.jpg "Sydney’s COVID cases were seen surpassing 2,000 a day; Australia increases vaccines")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PYUKIFPVQFNLLD75RVZ3BMVPSA.jpg "Fauci says Pfizer is on its way to vaccine promoters in the United States")